Plaintiffs in the litigation report experiencing these specific digestive system complications: Gastroparesis (stomach paralysis): The most common injury alleged in lawsuits, this condition involves partial or complete paralysis of stomach muscles that prevents proper digestion and can persist even after discontinuing medication Ileus (intestinal blockage): Added to FDA warning labels in September 2023 after post-marketing reports, this condition stops intestinal movement and can lead to life-threatening complications including infection and tissue death Intestinal obstruction and pseudo-obstruction: Physical or functional blockages requiring emergency hospitalization and often surgical intervention to prevent bowel perforation Chronic severe symptoms: Persistent vomiting, uncontrollable nausea, dangerous dehydration requiring IV fluids, and electrolyte imbalances necessitating repeated emergency department visits The FDAs decision to update warning labels demonstrates growing concern about these complications
Providers who know your name Real nurse practitioners and clinicians, based in the U.S
Ozempic: the truth about new weight-loss drugs Wegovy study finds weight-loss drug sharply cuts heart attacks, strokes and cardiac deaths What to do about fake weight-loss drugs and compounded versions Nutrition is vital when taking GLP-1 weight-loss drugs
What About Heart Rate
Mix things up so you dont get bored swap quinoa for brown rice, or switch your greens from spinach to kale
After decades of focusing on nutrition and lifestyle coaching, WeightWatchers partnered with Novo Nordisk to offer GLP-1 medications like Wegovy alongside its signature Points system
